- Report
- July 2026
- 200 Pages
Global
From €7110EUR$7,990USD£6,103GBP
- Report
- July 2026
- 120 Pages
Global
From €4227EUR$4,750USD£3,628GBP
- Report
- July 2026
- 130 Pages
Global
From €4227EUR$4,750USD£3,628GBP
- Report
- April 2026
- 208 Pages
Global
From €3500EUR$4,213USD£3,110GBP
- Report
- October 2025
- 150 Pages
Global
From €4316EUR$4,850USD£3,705GBP
- Report
- May 2026
- 150 Pages
United States
From €2482EUR$2,789USD£2,130GBP
- Report
- August 2023
- 1500 Pages
Global
From €7786EUR$8,750USD£6,684GBP
From €3114EUR$3,500USD£2,674GBP
From €3995EUR$4,490USD£3,430GBP
- Report
- November 2024
- 283 Pages
Global
From €4405EUR$4,950USD£3,781GBP
- Report
- May 2024
- 318 Pages
Global
From €3177EUR$3,570USD£2,727GBP
€3737EUR$4,200USD£3,208GBP
- Report
- August 2025
- 192 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- August 2025
- 199 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- July 2023
- 284 Pages
Global
From €2447EUR$2,750USD£2,101GBP
€4894EUR$5,500USD£4,201GBP
- Report
- April 2023
- 160 Pages
Global
From €5295EUR$5,950USD£4,545GBP
- Report
- October 2023
- 207 Pages
India
From €1757EUR$1,975USD£1,509GBP
€3515EUR$3,950USD£3,017GBP
- Report
- August 2025
- 195 Pages
Global
From €3155EUR$3,545USD£2,708GBP
€3505EUR$3,939USD£3,009GBP
- Report
- March 2025
- 85 Pages
Saudi Arabia
From €3114EUR$3,500USD£2,674GBP
From €3114EUR$3,500USD£2,674GBP
- Report
- July 2026
- 90 Pages
Australia
From €4227EUR$4,750USD£3,628GBP

The Antimicrobial Susceptibility Testing (AST) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. AST is used to determine the effectiveness of antibiotics against a particular strain of bacteria, and is used to guide clinical decisions in the treatment of infectious diseases. AST tests are used to identify the most effective antibiotic for a particular infection, and to detect the emergence of antibiotic resistance. AST tests are used in both clinical and research settings, and are becoming increasingly important as antibiotic resistance continues to rise.
The AST market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the need for personalized medicine. The market is further supported by the increasing adoption of automated systems, which reduce the time and cost associated with manual testing.
Notable companies in the AST market include bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Bruker, and Hologic. Show Less Read more